Industry news round-up: updates from December 2023
Discover the latest industry developments in real-world data (RWD) and real-world evidence (RWE) research from December 2023 in our regular monthly column.
GE HealthCare to develop real-world data platform and AI-screening for pioneer early Alzheimer’s detection PREDICTOM project
GE HealthCare announces key role in harnessing RWD coupled with AI-screening to pioneer early detection of Alzheimer’s disease in the European PREDICTOM project.
Syapse and FDA renew collaboration to advance use of real-world data and evidence in oncology
Syapse announces 4-year extension of collaboration with FDA to explore fit-for-purpose RWD and RWE study design in oncology regulatory science.
HealthPartners Institute’s international diabetes center to uncover real-world evidence on the economic impact of continuous glucose monitors in type 2 diabetes management
With recent supplemental funding from the Patient-Centered Outcomes Research Institute (PCORI), HealthPartners Institute will expand clinical effectiveness research into the real-world economic impact of continuous glucose monitors on type 2 diabetes management, delving into ‘financial toxicity’ and how regional variations affect the financial strain of managing the disease.
Register here for our latest webinar where experts will highlight the results of a real-world GLP-1 comparative effectiveness study and the impact of timely and representative RWD in assessing performance of new therapies.
Verily’s clinical-grade smartwatch, empowered by real-world evidence, revolutionizes atrial fibrillation monitoring
A new clinical-grade smartwatch developed by Verily Life Sciences leverages RWD for highly accurate atrial fibrillation detection through continuous monitoring, marking a significant stride in wearable technology for personalized health care.
OPEN Health announces partnership with Nested Knowledge to advance healthcare evidence generation with AI technology
Global healthcare consultancy OPEN Health has issued a press release announcing a new formal alliance with Nested Knowledge to deploy its AI-powered clinical literature review platform to advance healthcare evidence generation.
xCures and Aetion expand partnership, broadening access to valuable real-world evidence for enhanced oncology research
xCures and Aetion have strengthened their partnership to provide access to five comprehensive oncology datasets, significantly expanding the pool of RWE available for advancing cancer research.
ConcertAI acquires CancerLinQ to advance use of real-world evidence for oncology solutions
ConcertAI has invested in CancerLinQ, marking a significant step towards providing its members with enhanced quality reporting, industry-leading RWD and AI-powered solutions for more streamlined clinical trials.
C-Path and PicnicHealth form strategic partnership to advance rare disease research using real-world evidence
Critical Path Institute, an independent, nonprofit involved in advancing rare disease research, has unveiled a strategic data collaboration with PicnicHealth, a company dedicated to patient-centric healthcare evidence generation.
Premier, Inc.’s PINC AI Applied Sciences and TFS HealthScience partner on AI-powered real-world data
Integrating AI technology and clinical development expertise, the collaboration between Premier, Inc.’s PINC AI Applied Sciences and TFS HealthScience aims to optimize recruitment, reach underrepresented populations, and expedite commercialization.
Komodo Health and the University of Washington CHOICE Institute partner to progress real-world health economics and outcomes research
CHOICE Institute of the University of Washington School of Pharmacy chooses Komodo Health to be their new RWD and technology partner to advance health economics and outcomes research.
ACSR and Proscia partnership spearheads rapid equitable distribution of real-world digital pathology data to drive HIV and cancer research
Proscia enterprise digital pathology platform enables the AIDS and Cancer Specimen Resource to provide near real-time access to digital real-world pathology data to investigators around the world.
Atropos Health and SEQSTER collaborate to streamline patient registry deployment and expand real-world evidence accessibility
Atropos Health and SEQSTER have partnered to simplify the establishment of patient registries and enhance the availability of RWE, accelerating evidence generation and driving advancements in research for underserved populations.
